GlassScriptPhysician profile
David D Richardson
NPI 1578553921
$25,138.35
in general payments reported to CMS, 2019-2025
19 companies · $817 in 2025
The $817 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22K · 2020: $434 · 2021: $284 · 2022: $324 · 2023: $330 · 2024: $764 · 2025: $817.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,324 · Debt Forgiveness: $588.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,323.61 |
| Debt Forgiveness | $587.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ellexiscience | $21,563.83 | 2019 | |
| Alcon Vision LLC | $648.85 | 2022-2025 | Rocklatan, Luxor, Ngenuity |
| Carl Zeiss Meditec USA, INC. | $587.82 | 2024 | |
| Sight Sciences, INC. | $530.44 | 2021-2023 | Omni Surgical System |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $475.58 | 2019 | |
| Allergan, INC. | $249.00 | 2019-2021 | |
| Glaukos Corporation | $210.75 | 2019-2024 | Istent Infinite Trabecular Micro Bypass System |
| Bausch & Lomb Americas INC. | $166.04 | 2022-2024 | Miebo, Xiidra |
| Rxsight INC | $161.24 | 2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Contact Lens |
| Ivantis, INC | $154.09 | 2020 | |
| Johnson & Johnson Surgical Vision, INC. | $116.99 | 2025 | Tecnis Iol |
| Lumibird Medical INC. | $87.49 | 2020 | |
| Sun Pharmaceutical Industries INC. | $65.12 | 2025 | |
| Lkc Technologies, INC. | $23.27 | 2023 | |
| Aerie Pharmaceuticals, INC. | $23.07 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $20.13 | 2022 | |
| Thea Pharma INC. | $19.94 | 2023 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Ocular Therapeutix, INC. | $15.30 | 2024 | Dextenza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Richardson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.